Phenotype variations in Gaucher disease.
The Gaucher phenotype is very complex and it cannot be simply evaluated on the basis of blood counts or splenomegaly, but by the analysis of all disease compartments. To establish the diagnosis of Gaucher disease, biochemical assay of glucocerebrosidase activity is the most reliable method. However, it can be supplemented by molecular diagnosis, which may be helpful to predict the severity and the rate of progression of clinical manifestations. The genotype-phenotype correlations are very complex with a high inter-individual variability in the severity of clinical manifestations within a same genotype. Genetic modifiers may play an important role in determining the eventual Gaucher phenotype. Despite of some devastating complications, which can arise with advancing age, Gaucher disease worsen progressively in the majority of patients homozygous for the N370S mutation. The analysis of the data of the International Collaborative Gaucher Group registry should provide a better understanding of the natural history of the Gaucher disease.
Mistry
P
P
Yale University School of Medicine, Internal Medicine, New Haven, CT 06520, USA.
Germain
D P
DP
D000328:Adult; D000367:Age Factors; D000368:Aged; D000483:Alleles; D002648:Child; D002675:Child, Preschool; D018450:Disease Progression; D005500:Follow-Up Studies; D005776:Gaucher Disease / Q000150:complications / Q000175:diagnosis / Q000201:enzymology / Q000235:genetics*; D018740:Genetic Heterogeneity; D005838:Genotype; D005962:Glucosylceramidase / Q000097:blood; D006720:Homozygote; D006801:Humans; D007585:Jews / Q000235:genetics; D008297:Male; D008875:Middle Aged; D009154:Mutation; D010641:Phenotype; D012042:Registries; D013163:Splenomegaly / Q000209:etiology; D013997:Time Factors
D005962:Glucosylceramidase